Detalles de la búsqueda
1.
Etrasimod as induction and maintenance therapy for ulcerative colitis (ELEVATE): two randomised, double-blind, placebo-controlled, phase 3 studies.
Lancet
; 401(10383): 1159-1171, 2023 04 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-36871574
2.
Tolerability of Ig20Gly during onboarding in patients with primary immunodeficiency diseases.
Ann Allergy Asthma Immunol
; 123(3): 271-279.e1, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31228628
3.
A Novel Targeted Screening Tool for Hypogammaglobulinemia: Measurement of Serum Immunoglobulin (IgG, IgM, IgA) Levels from Dried Blood Spots (Ig-DBS Assay).
J Clin Immunol
; 35(6): 573-82, 2015 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-26275445
4.
Achievement of Clinical, Endoscopic, and Histological Outcomes in Patients with Ulcerative Colitis Treated with Etrasimod, and Association with Faecal Calprotectin and C-reactive Protein: Results From the Phase 2 OASIS Trial.
J Crohns Colitis
; 18(6): 885-894, 2024 Jun 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-38245818
5.
Infection rates and tolerability of three different immunoglobulin administration modalities in patients with primary immunodeficiency diseases.
Immunotherapy
; 14(4): 215-224, 2022 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-34931880
Resultados
1 -
5
de 5
1
Próxima >
>>